Wockhardt Medicines Limited - Company Profile

Q: Where is Wockhardt Medicines Limited headquartered?

Wockhardt Medicines Limited is headquartered at A501, 5Th Floor, Kanakia Zillion, Next To Kurla Bus Depot, Kurla, Mumbai, Maharashtra, 400070.

Q: Who are the current directors of Wockhardt Medicines Limited?

The current directors of Wockhardt Medicines Limited are Stephen Sabbas Dsouza, Sujatha Shashikant Shetty, Janet Gonsalves.

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 2019.

2019 Mumbai, Maharashtra, India Active

Last Updated: January 06, 2026

Access Report

About Wockhardt Medicines Limited

Wockhardt Medicines Limited, a active public limited company, was established on 25 March 2019 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U74999MH2019PLC322942. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.

It upholds a compliant status. Its leadership includes Stephen Sabbas Dsouza (Director), Sujatha Shashikant Shetty (Director), Janet Gonsalves (Director). Past directors included Shobhana Satish Nagwekar, Sujatha Shashikant Shetty, Janet Gonsalves. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at A/501, 5Th Floor, Kanakia Zillion, Next To Kurla Bus Depot, Kurla, Mumbai, Maharashtra, 400070.

Company Details

CIN/LLPIN
U74999MH2019PLC322942
Registration Number
322942
Incorporation Date
25 March 2019
Authorized Capital
₹1.00 M
Paid-Up Capital
₹0.50 M
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 1.00 M as on 06-01-2026
Paid Up Capital ₹ 0.50 M as on 06-01-2026
Company Age 6 Year, 10 Months
Last Filing with ROC 31 Mar 2025
Revenue Growth **** % (FY 2023)
Profit Growth **** -202.77% (FY 2023)
Ebitda **** -202.32% (FY 2023)
Net Worth -201.66% (FY 2023)
Total Assets **** 2371.43% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Wockhardt Medicines Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Wockhardt Medicines Limited?

Current Directors

Name	Designation	Appointment Date	Status
Stephen Sabbas Dsouza	Director	25 Mar 2019	Current
Sujatha Shashikant Shetty	Director	30 Mar 2021	Current
Janet Gonsalves	Director	01 Jun 2022	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	30 Mar 2021	Past
Pramod Abcsdd	Additional Director	30 Sep 2021	Past
Pramod Abcsdd	Additional Director	30 Sep 2022	Past
Pramod Abcsdd	Director	31 May 2022	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Wockhardt Medicines.

Wockhardt Medicines Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 202.77% decrease in profit. The company's net worth observed a substantial decline by a decrease of 201.66%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

2371.43%

*******

Profit or Loss

*******

-202.77%

*******

Net Worth

*******

-201.66%

*******

EBITDA

*******

-202.32%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Wockhardt Medicines?

In 2023, Wockhardt Medicines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Wockhardt Medicines?

Unlock and access historical data on people associated with Wockhardt Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Wockhardt Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wockhardt Medicines's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Wockhardt Medicines

Recent Activity within the Organization

Annual General Meeting

Wockhardt Medicines Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
30 Sep 2025
Balance Sheet

The activity Wockhardt Medicines Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
31 Mar 2025
Director Appointment

Janet Gonsalves was appointed as a Director was appointed as a Director on 01 Jun 2022 & has been associated with this company since 3 years 8 months . was recorded as a recent event.
01 Jun 2022
Director Appointment

Sujatha Shashikant Shetty was appointed as a Director was appointed as a Director on 30 Mar 2021 & has been associated with this company since 4 years 10 months . was recorded as a recent event.
30 Mar 2021
Director Appointment

The activity Stephen Sabbas Dsouza was appointed as a Director was appointed as a Director on 25 Mar 2019 & has been associated with this company since 6 years 10 months . was completed.
25 Mar 2019
Company Incorporation

Wockhardt Medicines Limited was registered on 25 Mar 2019 with Roc Mumbai & aged 6 years 10 months as per MCA records. was recorded as a recent event.
25 Mar 2019

Explore recent activity and updates - View Recent Activity